To examine whether MET suppression renders PC cells sensitive to olaparib by inducing HRR deficiency, we assessed the expression level of the DNA damage marker γH2AX in PC cell lines (DU145 and PC3) treated with either olaparib or crizotinib alone or in combination. This evidence concerns the gene MET and pachyonychia congenita.